McKesson, HCA Healthcare to form oncology research joint venture

Humana and Evolent expand partnership to enhance oncology care

Humana Inc. and Evolent Health Inc. announced an expansion of their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services.

November 15, 2024

Vol.50 No.43

In Brief

McKesson to acquire controlling stake in Florida Cancer Specialists & Research Institute’s Core Ventures

McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures).

September 06, 2024

Vol.50 No.33

Drugs & Targets

Shasqi, Johnson & Johnson expand existing research collaboration

Shasqi, Inc. and Johnson & Johnson Enterprise Innovation Inc. have expanded their ongoing research collaboration.

October 13, 2023

Vol.49 No.38

Drugs & Targets

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Pierre Fabre Laboratories and Vernalis, a fully owned subsidiary of HitGen Inc., established a long-term partnership to identify pre-clinical candidates against oncology targets.

September 29, 2023

Vol.49 No.36

Drugs & Targets

Veeva and Merck form long-term strategic partnership

Veeva Systems formed a ten-year strategic partnership agreement with Merck, that builds on the existing 12-year partnership between the companies. Under the terms of the agreement, Merck will take a Veeva-first approach to new industry-specific software and data, selecting Veeva products when they are fit for purpose to maximize the value of Veeva’s integrated, cloud-based platform and products.

November 04, 2022

Vol.48 No.40